Pharmacy News and Research

RSS

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy that allows the public access to their medications and advice about their health. Traditionally known as a chemist, it is the healthcare facility that is responsible for the provision of pharmaceutical service to a specific community group or region.

State roundup: Maine hospitals fighting for timely Medicaid payments

New York police plan to distribute "bait bottles" of fake pain-killers equipped with invisible GPS devices in a drive to combat the scourge of pharmacy robberies by addicts and sellers looking for oxycodone tablets, which can fetch more than $80 per pill on the street.

17 Jan 2013

First Edition: January 16, 2013

Today's headlines include reports examining how mental health issues play a role in efforts to curb gun violence and expand gun control efforts.

16 Jan 2013

Viewpoints: The country's deep health problems; Anthem's Rx policy in Calif. may not be legal; Wis. Gov. Medicaid decision looming

It is now shockingly clear that poor health is a much broader and deeper problem than past studies have suggested. An authoritative report issued by the Institute of Medicine this week found that, on average, Americans experience higher rates of disease and injury and die sooner than people in other high-income countries.

15 Jan 2013

Cholera could be contained in Haiti by vaccinating less than half the population

Cholera could be contained in Haiti by vaccinating less than half the population, University of Florida researchers suggest in a paper to be published Thursday in the journal Scientific Reports.

11 Jan 2013

Mass. governor proposes new compounding pharmacy oversights

Massachusetts Gov. Deval Patrick is proposing the state exercise stricter control over compounding pharmacies by -- in part -- establishing new licensing requirements for the labs and letting the state assess fines against them if they break rules.

9 Jan 2013

Cost-ineffective drug prescribing practices revealed

Around four in 10 physicians prescribe a brand-name drug due to a patient request, when a generic equivalent is available, find researchers.

8 Jan 2013

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.

7 Jan 2013

New York Times profiles work of abortion hotline in Chile

The New York Times profiles the Safe Abortion Hot Line in Chile, where abortion has been entirely illegal since 1989.

7 Jan 2013

Clinical Nutrition now been revised and updated in a 2nd edition

One of the most important factors in recovering from illness is nutrition, and understanding the scientific basis which underpins nutritional support is a key requirement for nutrition students and professionals. The Nutrition Society was established in 1941 to advance the scientific study of nutrition and its application to the maintenance of human and animal health; to support that mission, the Society created the Nutrition Society Textbook Series, published by Wiley.

7 Jan 2013

Confusion surrounds regulation of various types of drug makers

Far from triggering a quick fix, the deaths or illnesses of 620 people in 19 states that have been linked to a Massachusetts pharmacy have only underscored confusion over how to regulate the various types of drug-makers in the United States.

4 Jan 2013

Roundup: Medicaid waiver challenges in Texas; Detailing Sandy's impact on NYC's mental care

By 2012's end, health care providers across Texas will have submitted proposals to state leaders to transform the way they care for the poor and uninsured. They have been spurred by a Medicaid waiver Texas officials sought and received in 2011 from the federal government, one that ties financing to cooperation, cost efficiency and better patient outcomes.

2 Jan 2013

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other lipid-lowering treatments.

27 Dec 2012

Roundup: Calif. hospitals fined over serious errors; Mass. pharmacy waiting period continues; Hospitals acquiring 'tough reimbursement climate' in Alabama?

Ten California hospitals received fines Thursday for errors that resulted in either serious injury or death to a patient. The California Department of Public Health issued a total of $785,000 in penalties for errors that include removing the wrong kidney, leaving surgical objects behind and failing to call for assistance when a patient began bleeding excessively (Gorman, 12/21).

21 Dec 2012

FDA seeks input from states on drug compounders

FDA Commissioner Margaret Hamburg convened a meeting that included federal officials and representatives from state boards of pharmacy and governors' offices. Meanwhile, the Los Angeles Times reports on "rogue pharmacists."

21 Dec 2012

Study identifies mechanisms responsible for regenerating blood vessels in the brain

New research from the University of Georgia identifies the mechanisms responsible for regenerating blood vessels in the brain.

20 Dec 2012

AAV-based gene therapy cocktail may help extend lives of children with Canavan disease

Results of a clinical trial that began in 2001 show that a gene therapy cocktail conveyed into the brain by a molecular special delivery vehicle may help extend the lives of children with Canavan disease, a rare and fatal neurodegenerative disorder.

20 Dec 2012

Roundup: States facing Medicaid woes; Experts say N.Y. squeezed; Colorado, N.C. govs extend funding for mental health care

Rising health care costs are pushing up the amounts states must spend on the Medicaid insurance program for the poor, sending some scrambling to find funds, according to a report released on Tuesday by the National Conference of State Legislatures. The report found that spending on Medicaid and other public health care programs is currently over budget in 10 states, compared to six states at the same point last year.

20 Dec 2012

Viewpoints: Does 'fiscal cliff' end justify the means?; A shrinking government under any plan; Wrongly confusing Asperger's with mental illness

It is the third week of December, and all of Washington is focused on whether the country will fall off the "fiscal cliff" it has built for itself. ... As of January 1, physicians' fees for treating Medicare patients are scheduled for an across-the-board reduction of about 27% in addition to the 2% reduction for all services relating to Medicare under sequestration.

19 Dec 2012

New data on drug use

Teenagers abuse prescription medication more than anything else besides marijuana. Tomorrow, the White House Office of National Drug Control Policy is set to release new data on youth drug use.

19 Dec 2012

Jagaricin and antifungal drugs: an interview with Prof Christian Hertweck

Most people have already experienced a fungal infection (mycosis) of the outer layer of the skin, athlete’s foot or ringworm. Whereas such infections may be cumbersome and often difficult to cure, usually they are not dangerous. However, in cases where a fungus causes a systemic infection, this is, it infects internal organs such as lungs or brain, the infection may turn into a life-threatening disease. Of course, only pathogenic fungi cause problems and the degree of virulence varies.

18 Dec 2012

Pharmacy News and Research

Further Reading

State roundup: Maine hospitals fighting for timely Medicaid payments

First Edition: January 16, 2013

Viewpoints: The country's deep health problems; Anthem's Rx policy in Calif. may not be legal; Wis. Gov. Medicaid decision looming

Cholera could be contained in Haiti by vaccinating less than half the population

Mass. governor proposes new compounding pharmacy oversights

Cost-ineffective drug prescribing practices revealed

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

New York Times profiles work of abortion hotline in Chile

Clinical Nutrition now been revised and updated in a 2nd edition

Confusion surrounds regulation of various types of drug makers

Roundup: Medicaid waiver challenges in Texas; Detailing Sandy's impact on NYC's mental care

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

Roundup: Calif. hospitals fined over serious errors; Mass. pharmacy waiting period continues; Hospitals acquiring 'tough reimbursement climate' in Alabama?

FDA seeks input from states on drug compounders

Study identifies mechanisms responsible for regenerating blood vessels in the brain

AAV-based gene therapy cocktail may help extend lives of children with Canavan disease

Roundup: States facing Medicaid woes; Experts say N.Y. squeezed; Colorado, N.C. govs extend funding for mental health care

Viewpoints: Does 'fiscal cliff' end justify the means?; A shrinking government under any plan; Wrongly confusing Asperger's with mental illness

New data on drug use

Jagaricin and antifungal drugs: an interview with Prof Christian Hertweck

Pittcon Highlights: Pharmaceutical & Biologic eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News